Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 10.85
-0.55 (-4.82%)
Aug 1, 2025, 1:38 PM CST
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 1.85 billion as of August 1, 2025. Its market cap has decreased by -48.71% in one year.
Market Cap
1.85B
Enterprise Value
2.00B
Revenue
40.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.85
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has increased from 1.15B to 1.85B, an increase of 61.24%. That is a compound annual growth rate of 3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.85B | -26.69% |
| Dec 31, 2024 | 2.52B | -54.81% |
| Dec 29, 2023 | 5.58B | -34.69% |
| Dec 30, 2022 | 8.55B | -50.08% |
| Dec 30, 2021 | 17.12B | 165.10% |
| Dec 31, 2020 | 6.46B | 66.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 187.67B |
| PharmaEssentia | 165.47B |
| Bora Pharmaceuticals Co., LTD. | 85.03B |
| Lotus Pharmaceutical | 57.06B |
| Oneness Biotech | 30.42B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.57B |
| Pegavision | 24.02B |